Radiation therapy is used to treat more than half of all cancer cases, but patient response to therapy can vary greatly. Genetics is increasingly recognized as a significant contributor to inter-individual radiation response, but the biology underlying response remains poorly understood. Researchers have now employed a pharmacogenomics approach to find biomarkers associated with radiation response that could help to more effectively tailor individual cancer treatments in the future.